What is the most common chromosomal abnormality in a 12‑week abortus—aneuploidy or autosomal trisomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Chromosomal Abnormality in 12-Week Abortus

Autosomal trisomy is the most common chromosomal abnormality in 12-week abortuses, representing the predominant subtype within the broader category of aneuploidy.

Understanding the Terminology

The question presents a false dichotomy—autosomal trisomy is actually a specific type of aneuploidy, not a separate category. Aneuploidy refers to any abnormal number of chromosomes, which includes:

  • Autosomal trisomies (extra autosomal chromosome)
  • Monosomy X (missing sex chromosome)
  • Polyploidy (complete extra chromosome sets)
  • Sex chromosome aneuploidies

1, 2, 3, 4

Frequency of Chromosomal Abnormalities

Overall chromosomal abnormality rates in first-trimester miscarriages range from 47-70%, with the highest quality studies reporting:

  • 70.3% in a series of 1,011 consecutive chorionic villi samples 1
  • 67.25% in a large study of 7,118 miscarriages 4
  • 61% in 259 consecutive first-trimester miscarriages 3
  • 58.59% in 990 early missed abortion cases 5

1, 2, 3, 4

Autosomal Trisomy as the Predominant Abnormality

Among all chromosomal abnormalities detected in first-trimester losses, autosomal trisomies consistently represent 56-67% of abnormal cases:

  • Single autosomal trisomy accounted for 64.6% of abnormal karyotypes in the largest systematic study 1
  • Trisomies represented 67.24% of chromosomal abnormalities in recent CNV-seq analysis 5
  • 88.62% of abnormalities were numerical chromosomal abnormalities, with autosomal trisomies being the dominant subtype 5
  • Autosomal trisomies were found in 37% of all karyotyped samples (both normal and abnormal) 3

5, 1, 2, 3

Specific Trisomy Distribution

The most frequently encountered autosomal trisomies in 12-week abortuses are:

  • Trisomy 16: Most common overall, representing 14-19% of chromosomal abnormalities 5, 6, 3
  • Trisomy 22: Second most common at approximately 19% 5
  • Trisomy 21,18,13, and 15: Also frequently observed but less common than trisomy 16 1, 4

5, 6, 1, 3, 4

Other Chromosomal Abnormalities (Less Common)

Following autosomal trisomies in frequency:

  • Triploidy: 8-13% of abnormal cases 5, 1, 2
  • Monosomy X: 6-10% of abnormal cases 1, 2, 3
  • Structural rearrangements: 5-11% of abnormal cases 1, 2
  • Tetraploidy and other polyploidies: 1-2% 5, 6

5, 6, 1, 2, 3

Clinical Implications

The high rate of autosomal trisomies in early pregnancy losses reflects natural selection against chromosomally abnormal embryos:

  • Approximately 70% of trisomy 18 fetuses alive in the second trimester will be spontaneously lost by term 7
  • Most autosomal trisomies (except 13,18, and 21) are incompatible with survival beyond the first trimester 7
  • Trisomy 16, the most common abnormality in abortuses, is never seen in live births 3

7, 3

Important Caveats

When counseling patients about chromosomal abnormalities in miscarriage:

  • Maternal age significantly affects the rate of chromosomal abnormalities, increasing from 54.52% in women <35 years to 73.97% in women ≥40 years 5, 4
  • The proportion of autosomal trisomies increases with maternal age, while monosomy X and polyploidy decrease 5, 4
  • Cell-free DNA screening detects only trisomies 21,18, and 13, missing 16.9% of chromosomal abnormalities that would be detected by diagnostic testing 7
  • Cytogenetic analysis of miscarriage tissue provides definitive information for genetic counseling and future pregnancy planning 8, 1, 2

7, 8, 5, 1, 2, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.